PAUL J MADDON Insider Trading $PGNX PROGENICS PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL J MADDON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL J MADDON. PAUL J MADDON is CEO & CSO in PROGENICS PHARMACEUTICALS INC ($PGNX) and Chief Executive Officer/CSO in PROGENICS PHARMACEUTICALS INC ($PGNX) and CSO&ViceChairmanBOD in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in PROGENICS PHARMACEUTICALS INC ($PGNX).
PAUL J MADDON in PROGENICS PHARMACEUTICALS INC
Trading Symbol: PGNXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL J MADDON: Director, CSO&ViceChairmanBOD, Chief Executive Officer/CSO, CEO & CSO
Holdings: 854,057 shares
Current Value: $8,139,163
Latest Transaction: Jun 19 2014
$PGNX Market Capitalization: $671.09M
$PGNX Previous Close: $9.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PAUL J MADDON in PROGENICS PHARMACEUTICALS INC
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 19 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 12,000 | 63,960 | 652,828 | 640.8 K to 652.8 K (+1.87 %) |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 24.26 | 145,000 | 3,517,700 | 145,000 | |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 2,000 | 10,660 | 363,000 | |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 10,000 | 53,300 | 365,000 | |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 24.26 | 1,468 | 35,614 | 1,468 | |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 20.45 | 1,727 | 35,319 | 0 | |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Grant | A | 0.00 | 48,336 | 0 | 640,828 | 592.5 K to 640.8 K (+8.16 %) |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.84 | 2,000 | 47,674 | 592,492 | 594.5 K to 592.5 K (-0.34 %) |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 2,000 | 10,660 | 594,492 | 592.5 K to 594.5 K (+0.34 %) |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.84 | 10,000 | 238,370 | 592,492 | 602.5 K to 592.5 K (-1.66 %) |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 10,000 | 53,300 | 602,492 | 592.5 K to 602.5 K (+1.69 %) |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Payment of Exercise | F | 24.26 | 1,564 | 37,943 | 592,492 | 594.1 K to 592.5 K (-0.26 %) |
Jul 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 20.45 | 1,727 | 35,319 | 594,056 | 592.3 K to 594.1 K (+0.29 %) |
Jun 23 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 21.62 | 12,500 | 270,263 | 592,329 | 604.8 K to 592.3 K (-2.07 %) |
Jun 16 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 3,774 | 20,115 | 10,000 | |
Jun 16 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 6,000 | 31,980 | 13,774 | |
Jun 16 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 22.01 | 3,774 | 83,054 | 604,829 | 608.6 K to 604.8 K (-0.62 %) |
Jun 16 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 3,774 | 20,115 | 608,603 | 604.8 K to 608.6 K (+0.62 %) |
Jun 16 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 22.00 | 6,000 | 132,000 | 604,829 | 610.8 K to 604.8 K (-0.98 %) |
Jun 16 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 6,000 | 31,980 | 610,829 | 604.8 K to 610.8 K (+0.99 %) |
May 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 10,000 | 53,300 | 29,774 | |
May 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 20.91 | 10,000 | 209,090 | 604,829 | 614.8 K to 604.8 K (-1.63 %) |
May 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 10,000 | 53,300 | 614,829 | 604.8 K to 614.8 K (+1.65 %) |
Jun 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 3,000 | 15,990 | 19,774 | |
Jun 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 7,000 | 37,310 | 22,774 | |
Jun 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 21.88 | 3,000 | 65,643 | 604,829 | 607.8 K to 604.8 K (-0.49 %) |
Jun 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 3,000 | 15,990 | 607,829 | 604.8 K to 607.8 K (+0.50 %) |
Jun 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 21.79 | 7,000 | 152,509 | 604,829 | 611.8 K to 604.8 K (-1.14 %) |
Jun 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 7,000 | 37,310 | 611,829 | 604.8 K to 611.8 K (+1.16 %) |
May 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 10,000 | 53,300 | 39,774 | |
May 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 23.52 | 10,000 | 235,200 | 604,829 | 614.8 K to 604.8 K (-1.63 %) |
May 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 10,000 | 53,300 | 614,829 | 604.8 K to 614.8 K (+1.65 %) |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 2,500 | 13,325 | 49,774 | |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 2,500 | 13,325 | 52,274 | |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 2,500 | 13,325 | 54,774 | |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 2,500 | 13,325 | 57,274 | |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 25.47 | 2,500 | 63,675 | 604,829 | 607.3 K to 604.8 K (-0.41 %) |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 2,500 | 13,325 | 607,329 | 604.8 K to 607.3 K (+0.41 %) |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 24.90 | 2,500 | 62,250 | 604,829 | 607.3 K to 604.8 K (-0.41 %) |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 2,500 | 13,325 | 607,329 | 604.8 K to 607.3 K (+0.41 %) |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 24.86 | 2,500 | 62,150 | 604,829 | 607.3 K to 604.8 K (-0.41 %) |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 2,500 | 13,325 | 607,329 | 604.8 K to 607.3 K (+0.41 %) |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 24.78 | 2,500 | 61,950 | 604,829 | 607.3 K to 604.8 K (-0.41 %) |
Apr 18 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 2,500 | 13,325 | 607,329 | 604.8 K to 607.3 K (+0.41 %) |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 2,500 | 13,325 | 59,774 | |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 2,500 | 13,325 | 62,274 | |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 2,500 | 13,325 | 64,774 | |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 2,500 | 13,325 | 67,274 | |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 26.49 | 1,333 | 35,311 | 1,333 | |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 21.77 | 1,490 | 32,436 | 0 | |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 26.30 | 2,500 | 65,750 | 604,829 | 607.3 K to 604.8 K (-0.41 %) |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 2,500 | 13,325 | 607,329 | 604.8 K to 607.3 K (+0.41 %) |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 26.06 | 2,500 | 65,150 | 604,829 | 607.3 K to 604.8 K (-0.41 %) |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 2,500 | 13,325 | 607,329 | 604.8 K to 607.3 K (+0.41 %) |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 25.58 | 2,500 | 63,945 | 604,829 | 607.3 K to 604.8 K (-0.41 %) |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 2,500 | 13,325 | 607,329 | 604.8 K to 607.3 K (+0.41 %) |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 25.52 | 2,500 | 63,798 | 604,829 | 607.3 K to 604.8 K (-0.41 %) |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 2,500 | 13,325 | 607,329 | 604.8 K to 607.3 K (+0.41 %) |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Payment of Exercise | F | 25.61 | 1,356 | 34,727 | 604,829 | 606.2 K to 604.8 K (-0.22 %) |
Apr 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 21.77 | 1,490 | 32,436 | 606,185 | 604.7 K to 606.2 K (+0.25 %) |
Mar 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 10,000 | 53,300 | 69,774 | |
Mar 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 27.00 | 10,000 | 270,040 | 604,695 | 614.7 K to 604.7 K (-1.63 %) |
Mar 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 10,000 | 53,300 | 614,695 | 604.7 K to 614.7 K (+1.65 %) |
Mar 06 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Grant | A | 0.00 | 18,080 | 0 | 604,695 | 586.6 K to 604.7 K (+3.08 %) |
Mar 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 10,000 | 53,300 | 79,774 | |
Mar 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 29.02 | 10,000 | 290,210 | 586,615 | 596.6 K to 586.6 K (-1.68 %) |
Mar 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 10,000 | 53,300 | 596,615 | 586.6 K to 596.6 K (+1.70 %) |
Feb 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 10,000 | 53,300 | 89,774 | |
Feb 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 27.17 | 10,000 | 271,680 | 586,615 | 596.6 K to 586.6 K (-1.68 %) |
Feb 17 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 10,000 | 53,300 | 596,615 | 586.6 K to 596.6 K (+1.70 %) |
Feb 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 5.33 | 10,000 | 53,300 | 365,000 | |
Feb 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Sell | S | 27.73 | 10,000 | 277,270 | 586,615 | 596.6 K to 586.6 K (-1.68 %) |
Feb 03 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 5.33 | 10,000 | 53,300 | 596,615 | 586.6 K to 596.6 K (+1.70 %) |
Jan 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 25.01 | 2,341 | 58,548 | 2,341 | |
Jan 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 20.86 | 1,608 | 33,543 | 0 | |
Jan 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Payment of Exercise | F | 25.84 | 1,422 | 36,744 | 586,615 | 588 K to 586.6 K (-0.24 %) |
Jan 05 2006 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 20.86 | 1,608 | 33,543 | 588,037 | 586.4 K to 588 K (+0.27 %) |
Oct 05 2005 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 23.71 | 1,415 | 33,550 | 1,415 | |
Oct 05 2005 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | M | 16.81 | 1,996 | 33,553 | 0 | |
Oct 05 2005 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Payment of Exercise | F | 24.67 | 1,614 | 39,817 | 586,429 | 588 K to 586.4 K (-0.27 %) |
Oct 05 2005 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Buy | M | 16.81 | 1,996 | 33,553 | 588,043 | 586 K to 588 K (+0.34 %) |
Jul 06 2005 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 21.39 | 75,000 | 1,604,250 | 75,000 | |
Jul 06 2005 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Option Exercise | A | 20.86 | 1,308 | 27,285 | 1,308 | |
Jul 06 2005 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 586,047 | 561 K to 586 K (+4.46 %) |
Jul 06 2005 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | Chief Executive Off ... | Grant | A | 17.16 | 492 | 8,443 | 561,047 | 560.6 K to 561 K (+0.09 %) |
Jun 22 2005 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | CEO & CSO | Sell | S | 20.05 | 3,250 | 65,163 | 599,303 | 602.6 K to 599.3 K (-0.54 %) |
Jun 22 2005 | PGNX | PROGENICS PHARMACE ... | MADDON PAUL J | CEO & CSO | Sell | S | 20.00 | 3,000 | 60,000 | 602,553 | 605.6 K to 602.6 K (-0.50 %) |